25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

532612 (Indoco) Stock Analysis
Buy, Hold or Sell?

Let's analyze Indoco together

I guess you are interested in Indoco Remedies Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Indoco’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Indoco’s Price Targets

I'm going to help you getting a better view of Indoco Remedies Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Indoco Remedies Limited

I send you an email if I find something interesting about Indoco Remedies Limited.

1. Quick Overview

1.1. Quick analysis of Indoco (30 sec.)










1.2. What can you expect buying and holding a share of Indoco? (30 sec.)

How much money do you get?

How much money do you get?
INR0.10
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR120.44
Expected worth in 1 year
INR155.89
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
INR44.43
Return On Investment
14.9%

For what price can you sell your share?

Current Price per Share
INR298.80
Expected price per share
INR242.83 - INR337.21
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Indoco (5 min.)




Live pricePrice per Share (EOD)
INR298.80
Intrinsic Value Per Share
INR-372.35 - INR-106.13
Total Value Per Share
INR-251.91 - INR14.31

2.2. Growth of Indoco (5 min.)




Is Indoco growing?

Current yearPrevious yearGrowGrow %
How rich?$125.4m$116.1m$9.2m7.4%

How much money is Indoco making?

Current yearPrevious yearGrowGrow %
Making money$11.1m$16m-$4.9m-44.5%
Net Profit Margin5.4%8.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Indoco (5 min.)




2.4. Comparing to competitors in the Drugs - Generic industry (5 min.)




  Industry Rankings (Drugs - Generic)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Indoco?

Welcome investor! Indoco's management wants to use your money to grow the business. In return you get a share of Indoco.

First you should know what it really means to hold a share of Indoco. And how you can make/lose money.

Speculation

The Price per Share of Indoco is INR298.80. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Indoco.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Indoco, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR120.44. Based on the TTM, the Book Value Change Per Share is INR8.86 per quarter. Based on the YOY, the Book Value Change Per Share is INR13.41 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR2.25 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Indoco.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.120.0%0.120.0%0.170.1%0.160.1%0.130.0%0.100.0%
Usd Book Value Change Per Share0.100.0%0.100.0%0.150.1%0.140.0%0.110.0%0.080.0%
Usd Dividend Per Share0.030.0%0.030.0%0.030.0%0.020.0%0.020.0%0.020.0%
Usd Total Gains Per Share0.130.0%0.130.0%0.180.1%0.160.1%0.130.0%0.100.0%
Usd Price Per Share3.71-3.71-3.68-3.88-3.45-3.21-
Price to Earnings Ratio30.74-30.74-21.09-24.75-36.56--31.05-
Price-to-Total Gains Ratio29.58-29.58-20.79-24.53-37.78--23.35-
Price to Book Ratio2.73-2.73-2.92-3.16-3.16-3.61-
Price-to-Total Gains Ratio29.58-29.58-20.79-24.53-37.78--23.35-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.37644
Number of shares296
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.02
Usd Book Value Change Per Share0.100.11
Usd Total Gains Per Share0.130.13
Gains per Quarter (296 shares)37.1537.07
Gains per Year (296 shares)148.61148.28
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
13011913918130138
26023728836261286
39035643753391434
412047458671522582
515059373589652730
6180711884107783878
721083010331259131026
8241948118214310441174
92711067133116011741322
103011185148017813051470

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%10.01.00.090.9%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%10.01.00.090.9%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%10.01.00.090.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Indoco Remedies Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--8.8608.8600%13.414-34%12.332-28%9.751-9%7.081+25%
Book Value Per Share--120.444120.4440%111.584+8%110.066+9%97.479+24%82.187+47%
Current Ratio--1.5591.5590%1.917-19%1.765-12%1.611-3%1.502+4%
Debt To Asset Ratio--0.4820.4820%0.380+27%0.418+15%0.427+13%0.429+12%
Debt To Equity Ratio--0.9320.9320%0.613+52%0.729+28%0.754+24%0.761+23%
Dividend Per Share--2.2472.2470%2.2490%1.997+12%1.332+69%1.527+47%
Enterprise Value--20144118400.00020144118400.0000%23819341720.000-15%24338633746.667-17%21567502176.000-7%20619519764.000-2%
Eps--10.68510.6850%15.437-31%14.307-25%11.127-4%8.603+24%
Ev To Sales Ratio--1.1081.1080%1.427-22%1.474-25%1.472-25%1.750-37%
Free Cash Flow Per Share---29.298-29.2980%-3.083-89%-9.039-69%-3.910-87%-2.472-92%
Free Cash Flow To Equity Per Share--1.1341.1340%-0.609+154%0.325+249%-0.327+129%-0.083+107%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---106.132----------
Intrinsic Value_10Y_min---372.353----------
Intrinsic Value_1Y_max---4.242----------
Intrinsic Value_1Y_min---16.333----------
Intrinsic Value_3Y_max---17.617----------
Intrinsic Value_3Y_min---67.536----------
Intrinsic Value_5Y_max---36.867----------
Intrinsic Value_5Y_min---138.579----------
Market Cap27534539520.000-10%30271406400.00030271406400.0000%29999562720.000+1%31656734080.000-4%28169455776.000+7%26196976464.000+16%
Net Profit Margin--0.0540.0540%0.085-36%0.080-32%0.067-20%0.062-13%
Operating Margin----0%-0%-0%0.022-100%0.066-100%
Operating Ratio--0.3510.3510%0.354-1%0.348+1%0.529-34%0.908-61%
Pb Ratio2.481-10%2.7272.7270%2.918-7%3.160-14%3.155-14%3.607-24%
Pe Ratio27.965-10%30.74530.7450%21.089+46%24.750+24%36.563-16%-31.055+201%
Price Per Share298.800-10%328.500328.5000%325.550+1%343.533-4%305.690+7%284.285+16%
Price To Free Cash Flow Ratio-10.199+9%-11.212-11.2120%-105.585+842%-15.087+35%95.898-112%74.118-115%
Price To Total Gains Ratio26.901-10%29.57529.5750%20.785+42%24.526+21%37.776-22%-23.346+179%
Quick Ratio--0.7120.7120%0.859-17%0.770-7%0.685+4%0.657+8%
Return On Assets--0.0460.0460%0.086-46%0.079-42%0.065-29%0.061-24%
Return On Equity--0.0890.0890%0.138-36%0.133-33%0.111-20%0.103-14%
Total Gains Per Share--11.10711.1070%15.663-29%14.329-22%11.083+0%8.608+29%
Usd Book Value--125418711.300125418711.3000%116192430.800+8%114611824.467+9%101504550.680+24%85581782.830+47%
Usd Book Value Change Per Share--0.1000.1000%0.152-34%0.139-28%0.110-9%0.080+25%
Usd Book Value Per Share--1.3611.3610%1.261+8%1.244+9%1.102+24%0.929+47%
Usd Dividend Per Share--0.0250.0250%0.0250%0.023+12%0.015+69%0.017+47%
Usd Enterprise Value--227628537.920227628537.9200%269158561.436-15%275026561.337-17%243712774.589-7%233000573.333-2%
Usd Eps--0.1210.1210%0.174-31%0.162-25%0.126-4%0.097+24%
Usd Free Cash Flow---30507773.900-30507773.9000%-3210635.100-89%-9412440.467-69%-4070969.640-87%-2574196.500-92%
Usd Free Cash Flow Per Share---0.331-0.3310%-0.035-89%-0.102-69%-0.044-87%-0.028-92%
Usd Free Cash Flow To Equity Per Share--0.0130.0130%-0.007+154%0.004+249%-0.004+129%-0.001+107%
Usd Market Cap311140296.576-10%342066892.320342066892.3200%338995058.736+1%357721095.104-4%318314850.269+7%296025834.043+16%
Usd Price Per Share3.376-10%3.7123.7120%3.679+1%3.882-4%3.454+7%3.212+16%
Usd Profit--11125991.30011125991.3000%16074419.500-31%14897584.767-25%11586432.400-4%8958011.720+24%
Usd Revenue--205353453.600205353453.6000%188553054.300+9%189337217.800+8%166669589.560+23%139558978.730+47%
Usd Total Gains Per Share--0.1260.1260%0.177-29%0.162-22%0.125+0%0.097+29%
 EOD+3 -5MRQTTM+0 -0YOY+12 -253Y+11 -265Y+18 -2010Y+24 -14

3.3 Fundamental Score

Let's check the fundamental score of Indoco Remedies Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1527.965
Price to Book Ratio (EOD)Between0-12.481
Net Profit Margin (MRQ)Greater than00.054
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.712
Current Ratio (MRQ)Greater than11.559
Debt to Asset Ratio (MRQ)Less than10.482
Debt to Equity Ratio (MRQ)Less than10.932
Return on Equity (MRQ)Greater than0.150.089
Return on Assets (MRQ)Greater than0.050.046
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Indoco Remedies Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.388
Ma 20Greater thanMa 50281.173
Ma 50Greater thanMa 100301.784
Ma 100Greater thanMa 200283.200
OpenGreater thanClose308.850
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Indoco Remedies Limited

Indoco Remedies Limited manufactures and sells formulations and active pharmaceutical ingredients in India and internationally. The company offers respiratory products, such as Karvol Plus, Febrex Plus, and Tuspel; stomatologicals products that include Sensodent-K, Sensoform, Sensodent-KF, Snowdent, Kidodent, Rexidin Plus, and Dentogel; gastro intestinal products, such as Carmicide, Cyclopam, Carmicide Drops, Cyclomeff, and Nosic; pain/analgesics products that include Lignox and T-lac; and opthalmological products, such as Renolen, Homide, Tobaren DM, and Mofloren-D. It also provides vitamins/minerals/nutrients that include Methycal, MCBM 69, SM Fibro, Durashape, Trucharge, and Apispur; Urology products, such as Cital, Cital UTI, and Cital-H; Cloben-G and Scabex for derma; ATM for anti-invectives; Otorex for otologicals; Obi X and KG-Low for anti-obesity; Hemsyl for blood related; Dexoren for Opthal/Otologicals; and Vepan, bactogard, and Oxipod for anti-infectives. In addition, the company offers PGVISC eye drops; Aziltence for cardiac therapy; and D-Chiro for gynaec therapy. Further, it provides analytical services, such as impurity profile, particle size analysis, heavy metal analysis, polymorphism, compatibility, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Additionally, the company offers services that include architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. It serves general practitioners, pediatricians, consultant physicians, dentists, cardiologists, diabetologists, endocrinologists, and nephrologists. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.

Fundamental data was last updated by Penke on 2025-09-09 13:32:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Indoco earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compareΒ Indoco to theΒ Drugs - Generic industry mean.
  • A Net Profit Margin of 5.4%Β means thatΒ ₹0.05 for each ₹1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Indoco Remedies Limited:

  • The MRQ is 5.4%. The company is making a profit. +1
  • The TTM is 5.4%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ5.4%TTM5.4%0.0%
TTM5.4%YOY8.5%-3.1%
TTM5.4%5Y6.7%-1.3%
5Y6.7%10Y6.2%+0.5%
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ5.4%5.4%+0.0%
TTM5.4%5.4%+0.0%
YOY8.5%8.5%+0.0%
3Y8.0%9.1%-1.1%
5Y6.7%6.7%+0.0%
10Y6.2%6.2%+0.0%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Indoco is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Indoco to theΒ Drugs - Generic industry mean.
  • 4.6% Return on Assets means thatΒ Indoco generatedΒ ₹0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Indoco Remedies Limited:

  • The MRQ is 4.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.6%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.6%TTM4.6%0.0%
TTM4.6%YOY8.6%-4.0%
TTM4.6%5Y6.5%-1.9%
5Y6.5%10Y6.1%+0.5%
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ4.6%4.6%0.0%
TTM4.6%4.6%0.0%
YOY8.6%7.9%+0.7%
3Y7.9%7.7%+0.2%
5Y6.5%6.5%+0.0%
10Y6.1%6.1%0.0%
4.3.1.3. Return on Equity

Shows how efficient Indoco is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Indoco to theΒ Drugs - Generic industry mean.
  • 8.9% Return on Equity means Indoco generated ₹0.09Β for eachΒ ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Indoco Remedies Limited:

  • The MRQ is 8.9%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 8.9%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ8.9%TTM8.9%0.0%
TTM8.9%YOY13.8%-5.0%
TTM8.9%5Y11.1%-2.2%
5Y11.1%10Y10.3%+0.8%
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ8.9%8.9%0.0%
TTM8.9%8.9%0.0%
YOY13.8%13.8%+0.0%
3Y13.3%13.3%0.0%
5Y11.1%11.1%0.0%
10Y10.3%10.4%-0.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Indoco Remedies Limited.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Indoco is operatingΒ .

  • Measures how much profit Indoco makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Indoco to theΒ Drugs - Generic industry mean.
  • An Operating Margin of 0.0%Β means the company generated ₹0.00 Β for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Indoco Remedies Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y2.2%-2.2%
5Y2.2%10Y6.6%-4.4%
4.3.2.2. Operating Ratio

Measures how efficient Indoco is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Drugs - Generic industry mean).
  • An Operation Ratio of 0.35 means that the operating costs are ₹0.35 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Indoco Remedies Limited:

  • The MRQ is 0.351. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.351. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.351TTM0.3510.000
TTM0.351YOY0.354-0.002
TTM0.3515Y0.529-0.178
5Y0.52910Y0.908-0.378
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3510.457-0.106
TTM0.3510.457-0.106
YOY0.3540.530-0.176
3Y0.3480.505-0.157
5Y0.5290.529+0.000
10Y0.9080.982-0.074
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Indoco Remedies Limited.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Indoco is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Drugs - Generic industry mean).
  • A Current Ratio of 1.56Β means the company has ₹1.56 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Indoco Remedies Limited:

  • The MRQ is 1.559. The company is able to pay all its short-term debts. +1
  • The TTM is 1.559. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.559TTM1.5590.000
TTM1.559YOY1.917-0.357
TTM1.5595Y1.611-0.052
5Y1.61110Y1.502+0.109
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5591.559+0.000
TTM1.5591.559+0.000
YOY1.9171.614+0.303
3Y1.7651.612+0.153
5Y1.6111.6110.000
10Y1.5021.394+0.108
4.4.3.2. Quick Ratio

Measures if Indoco is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Indoco to theΒ Drugs - Generic industry mean.
  • A Quick Ratio of 0.71Β means the company can pay off ₹0.71 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Indoco Remedies Limited:

  • The MRQ is 0.712. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.712. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.712TTM0.7120.000
TTM0.712YOY0.859-0.146
TTM0.7125Y0.685+0.028
5Y0.68510Y0.657+0.028
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7120.712+0.000
TTM0.7120.712+0.000
YOY0.8590.8590.000
3Y0.7700.770+0.000
5Y0.6850.6850.000
10Y0.6570.6570.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Indoco Remedies Limited.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of IndocoΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Indoco to Drugs - Generic industry mean.
  • A Debt to Asset Ratio of 0.48Β means that Indoco assets areΒ financed with 48.2% credit (debt) and the remaining percentage (100% - 48.2%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Indoco Remedies Limited:

  • The MRQ is 0.482. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.482. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.482TTM0.4820.000
TTM0.482YOY0.380+0.103
TTM0.4825Y0.427+0.056
5Y0.42710Y0.429-0.002
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4820.486-0.004
TTM0.4820.486-0.004
YOY0.3800.513-0.133
3Y0.4180.532-0.114
5Y0.4270.527-0.100
10Y0.4290.561-0.132
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Indoco is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Indoco to theΒ Drugs - Generic industry mean.
  • A Debt to Equity ratio of 93.2% means that company has ₹0.93 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Indoco Remedies Limited:

  • The MRQ is 0.932. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.932. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.932TTM0.9320.000
TTM0.932YOY0.613+0.320
TTM0.9325Y0.754+0.179
5Y0.75410Y0.761-0.007
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9320.945-0.013
TTM0.9320.945-0.013
YOY0.6131.051-0.438
3Y0.7291.158-0.429
5Y0.7541.134-0.380
10Y0.7611.291-0.530
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every ₹1 in earnings Indoco generates.

  • Above 15 is considered overpriced butΒ always compareΒ Indoco to theΒ Drugs - Generic industry mean.
  • A PE ratio of 30.74 means the investor is paying ₹30.74Β for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Indoco Remedies Limited:

  • The EOD is 27.965. Based on the earnings, the company is overpriced. -1
  • The MRQ is 30.745. Based on the earnings, the company is overpriced. -1
  • The TTM is 30.745. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD27.965MRQ30.745-2.780
MRQ30.745TTM30.7450.000
TTM30.745YOY21.089+9.656
TTM30.7455Y36.563-5.818
5Y36.56310Y-31.055+67.617
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
EOD27.96527.965+0.000
MRQ30.74530.7450.000
TTM30.74530.7450.000
YOY21.08921.089+0.000
3Y24.75034.702-9.952
5Y36.56330.867+5.696
10Y-31.05518.028-49.083
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Indoco Remedies Limited:

  • The EOD is -10.199. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -11.212. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -11.212. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.199MRQ-11.212+1.014
MRQ-11.212TTM-11.2120.000
TTM-11.212YOY-105.585+94.373
TTM-11.2125Y95.898-107.111
5Y95.89810Y74.118+21.780
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-10.1995.438-15.637
MRQ-11.2125.246-16.458
TTM-11.2125.246-16.458
YOY-105.585-23.631-81.954
3Y-15.0870.024-15.111
5Y95.89836.577+59.321
10Y74.1182.281+71.837
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Indoco is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Drugs - Generic industry mean).
  • A PB ratio of 2.73 means the investor is paying ₹2.73Β for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Indoco Remedies Limited:

  • The EOD is 2.481. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.727. Based on the equity, the company is underpriced. +1
  • The TTM is 2.727. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.481MRQ2.727-0.247
MRQ2.727TTM2.7270.000
TTM2.727YOY2.918-0.190
TTM2.7275Y3.155-0.428
5Y3.15510Y3.607-0.452
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
EOD2.4812.4810.000
MRQ2.7272.727+0.000
TTM2.7272.727+0.000
YOY2.9182.9180.000
3Y3.1603.160+0.000
5Y3.1553.155+0.000
10Y3.6073.6070.000
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets21,447,285
Total Liabilities10,348,284
Total Stockholder Equity11,099,001
 As reported
Total Liabilities 10,348,284
Total Stockholder Equity+ 11,099,001
Total Assets = 21,447,285

Assets

Total Assets21,447,285
Total Current Assets9,546,683
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 141,337
Short-term Investments 79,659
Net Receivables 4,062,031
Inventory 3,720,571
Other Current Assets 119,011
Total Current Assets  (as reported)9,546,683
Total Current Assets  (calculated)8,122,609
+/- 1,424,074
Long-term Assets
Property Plant Equipment 8,910,853
Goodwill 215,211
Intangible Assets 1,664,945
Long-term Assets  (as reported)0
Long-term Assets  (calculated)10,791,009
+/- 10,791,009

Liabilities & Shareholders' Equity

Total Current Liabilities6,123,286
Long-term Liabilities0
Total Stockholder Equity11,099,001
Total Current Liabilities
Short-term Debt 2,565,509
Total Current Liabilities  (as reported)6,123,286
Total Current Liabilities  (calculated)2,565,509
+/- 3,557,777
Long-term Liabilities
Long term Debt Total 3,641,322
Capital Lease Obligations Min Short Term Debt-2,565,509
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)1,075,813
+/- 1,075,813
Total Stockholder Equity
Common Stock184,365
Retained Earnings 10,262,561
Capital Surplus 649,764
Other Stockholders Equity 2,311
Total Stockholder Equity (as reported)11,099,001
Total Stockholder Equity (calculated)11,099,001
+/-0
Other
Cash and Short Term Investments 220,996
Common Stock Shares Outstanding 92,150
Liabilities and Stockholders Equity 21,447,285
Net Working Capital 3,423,397



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
7,294,139
8,455,733
9,405,807
11,967,479
12,379,289
12,580,498
12,715,951
13,150,615
14,860,921
16,581,984
21,447,285
21,447,28516,581,98414,860,92113,150,61512,715,95112,580,49812,379,28911,967,4799,405,8078,455,7337,294,139
   > Total Current Assets 
3,045,600
3,853,564
4,645,510
5,720,503
5,389,612
5,380,522
5,631,038
6,225,262
7,736,191
8,135,680
9,546,683
9,546,6838,135,6807,736,1916,225,2625,631,0385,380,5225,389,6125,720,5034,645,5103,853,5643,045,600
       Cash And Cash Equivalents 
133,855
153,985
126,335
625,860
80,032
202,730
379,300
87,868
167,728
102,070
141,337
141,337102,070167,72887,868379,300202,73080,032625,860126,335153,985133,855
       Short-term Investments 
0
0
156,798
129,119
17,486
99,770
29,974
10
0
17,177
79,659
79,65917,17701029,97499,77017,486129,119156,79800
       Net Receivables 
1,383,970
1,557,055
1,888,339
2,156,777
2,095,059
1,958,372
2,101,439
2,338,238
2,972,446
3,509,404
4,062,031
4,062,0313,509,4042,972,4462,338,2382,101,4391,958,3722,095,0592,156,7771,888,3391,557,0551,383,970
       Inventory 
1,102,179
1,491,213
1,736,737
1,956,245
2,020,062
1,936,564
2,197,455
2,585,014
3,222,816
3,427,922
3,720,571
3,720,5713,427,9223,222,8162,585,0142,197,4551,936,5642,020,0621,956,2451,736,7371,491,2131,102,179
       Other Current Assets 
387,624
612,143
102,231
816,264
1,118,290
1,121,694
992,317
1,085,207
1,021,891
54,826
119,011
119,01154,8261,021,8911,085,207992,3171,121,6941,118,290816,264102,231612,143387,624
   > Long-term Assets 
0
0
0
6,244,848
6,989,677
7,199,976
7,084,913
0
0
0
0
00007,084,9137,199,9766,989,6776,244,848000
       Property Plant Equipment 
3,204,886
3,210,298
3,401,867
4,331,315
5,168,866
5,578,466
5,489,455
5,535,308
5,846,626
6,675,822
8,910,853
8,910,8536,675,8225,846,6265,535,3085,489,4555,578,4665,168,8664,331,3153,401,8673,210,2983,204,886
       Goodwill 
1,192
3,052
3,052
900
900
900
900
900
900
900
215,211
215,2119009009009009009009003,0523,0521,192
       Long Term Investments 
1,700
1,700
210
210
0
0
0
0
0
0
0
00000002102101,7001,700
       Intangible Assets 
489,426
811,830
879,417
973,015
1,074,420
951,425
914,093
845,121
918,781
1,241,787
1,664,945
1,664,9451,241,787918,781845,121914,093951,4251,074,420973,015879,417811,830489,426
       Long-term Assets Other 
0
0
0
436,910
0
0
-15
0
0
0
0
0000-1500436,910000
> Total Liabilities 
2,720,152
3,267,736
3,640,630
5,454,115
5,629,478
5,974,274
5,920,257
5,460,709
5,814,520
6,299,468
10,348,284
10,348,2846,299,4685,814,5205,460,7095,920,2575,974,2745,629,4785,454,1153,640,6303,267,7362,720,152
   > Total Current Liabilities 
2,021,463
2,621,217
3,029,519
3,903,870
4,173,612
4,455,012
4,589,864
4,069,199
4,248,536
4,245,070
6,123,286
6,123,2864,245,0704,248,5364,069,1994,589,8644,455,0124,173,6123,903,8703,029,5192,621,2172,021,463
       Short-term Debt 
919,941
965,431
872,316
1,183,580
1,099,314
1,133,937
1,059,786
1,163,238
1,037,330
1,183,710
2,565,509
2,565,5091,183,7101,037,3301,163,2381,059,7861,133,9371,099,3141,183,580872,316965,431919,941
       Short Long Term Debt 
919,941
965,431
1,398,233
2,795,369
1,591,478
1,688,376
1,658,752
0
0
0
0
00001,658,7521,688,3761,591,4782,795,3691,398,233965,431919,941
       Accounts payable 
706,611
1,198,556
1,313,111
1,640,293
1,495,497
1,707,227
1,656,037
0
0
0
0
00001,656,0371,707,2271,495,4971,640,2931,313,1111,198,556706,611
       Other Current Liabilities 
466,291
517,840
527,793
579,347
753,452
798,386
986,431
0
0
0
0
0000986,431798,386753,452579,347527,793517,840466,291
   > Long-term Liabilities 
0
0
0
1,616,074
1,455,858
1,519,262
1,330,393
0
0
0
0
00001,330,3931,519,2621,455,8581,616,074000
       Long term Debt Total 
0
0
378,853
1,323,097
1,232,759
1,286,571
1,024,211
1,039,444
1,068,472
1,585,368
3,641,322
3,641,3221,585,3681,068,4721,039,4441,024,2111,286,5711,232,7591,323,097378,85300
       Capital Lease Obligations 
0
0
0
0
0
0
60,085
0
0
0
0
000060,085000000
       Long-term Liabilities Other 
0
0
0
44,467
0
-1
1
0
0
0
0
00001-1044,467000
> Total Stockholder Equity
4,571,507
5,187,997
5,765,177
6,513,364
6,749,811
6,606,224
6,795,694
7,689,906
9,046,401
10,282,516
11,099,001
11,099,00110,282,5169,046,4017,689,9066,795,6946,606,2246,749,8116,513,3645,765,1775,187,9974,571,507
   Common Stock
184,301
184,301
184,301
184,301
184,301
184,301
184,301
184,301
184,301
184,301
184,365
184,365184,301184,301184,301184,301184,301184,301184,301184,301184,301184,301
   Retained Earnings 
3,751,587
4,356,642
4,937,314
5,687,010
5,923,451
5,779,830
5,969,300
6,863,512
8,220,007
9,456,138
10,262,561
10,262,5619,456,1388,220,0076,863,5125,969,3005,779,8305,923,4515,687,0104,937,3144,356,6423,751,587
   Accumulated Other Comprehensive Income 00000000000
   Capital Surplus 
0
0
644,195
642,093
642,093
642,093
642,093
642,093
642,093
642,093
649,764
649,764642,093642,093642,093642,093642,093642,093642,093644,19500
   Treasury Stock00000000000



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2025-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue16,649,200
Cost of Revenue-4,981,800
Gross Profit11,667,40011,667,400
 
Operating Income (+$)
Gross Profit11,667,400
Operating Expense--
Operating Income-135,90011,667,400
 
Operating Expense (+$)
Research Development-
Selling General Administrative3,940,500
Selling And Marketing Expenses-
Operating Expense-3,940,500
 
Net Interest Income (+$)
Interest Income662,300
Interest Expense--
Other Finance Cost-662,300
Net Interest Income-
 
Pretax Income (+$)
Operating Income-135,900
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-743,700-135,900
EBIT - interestExpense = 0
-737,400
-737,400
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--743,700
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-743,700
Tax Provision-35,800
Net Income From Continuing Ops--779,500
Net Income-737,400
Net Income Applicable To Common Shares-737,400
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Technical Analysis of Indoco
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Indoco. The general trend of Indoco is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Indoco's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Indoco Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Indoco Remedies Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 294.24 < 320.87 < 337.21.

The bearish price targets are: 283.70 > 266.86 > 242.83.

Know someone who trades $532612? Share this with them.πŸ‘‡

Indoco Remedies Limited Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Indoco Remedies Limited. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Indoco Remedies Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Indoco Remedies Limited. The current macd is -1.93569073.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Indoco price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Indoco. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Indoco price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Indoco Remedies Limited Daily Moving Average Convergence/Divergence (MACD) ChartIndoco Remedies Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Indoco Remedies Limited. The current adx is 20.69.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Indoco shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Indoco Remedies Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Indoco Remedies Limited. The current sar is 272.92.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Indoco Remedies Limited Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Indoco Remedies Limited. The current rsi is 56.39. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Indoco Remedies Limited Daily Relative Strength Index (RSI) ChartIndoco Remedies Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Indoco Remedies Limited. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Indoco price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Indoco Remedies Limited Daily Stochastic Oscillator ChartIndoco Remedies Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Indoco Remedies Limited. The current cci is 196.25.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Indoco Remedies Limited Daily Commodity Channel Index (CCI) ChartIndoco Remedies Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Indoco Remedies Limited. The current cmo is 22.59.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Indoco Remedies Limited Daily Chande Momentum Oscillator (CMO) ChartIndoco Remedies Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Indoco Remedies Limited. The current willr is -49.66492926.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Indoco is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Indoco Remedies Limited Daily Williams %R ChartIndoco Remedies Limited Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Indoco Remedies Limited.

Indoco Remedies Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Indoco Remedies Limited. The current atr is 14.58.

Indoco Remedies Limited Daily Average True Range (ATR) ChartIndoco Remedies Limited Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Indoco Remedies Limited. The current obv is 233,449.

Indoco Remedies Limited Daily On-Balance Volume (OBV) ChartIndoco Remedies Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Indoco Remedies Limited. The current mfi is 94.81.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Indoco Remedies Limited Daily Money Flow Index (MFI) ChartIndoco Remedies Limited Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Indoco Remedies Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-05-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-19STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-05-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-05-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-06-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-03ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-07MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-07-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-18STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-07-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-08-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-08-06BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-08-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-08-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-09-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-09-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-09-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-12STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Indoco Remedies Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Indoco Remedies Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.388
Ma 20Greater thanMa 50281.173
Ma 50Greater thanMa 100301.784
Ma 100Greater thanMa 200283.200
OpenGreater thanClose308.850
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Indoco with someone you think should read this too:
  • Are you bullish or bearish on Indoco? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Indoco? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Indoco Remedies Limited

I send you an email if I find something interesting about Indoco Remedies Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Indoco Remedies Limited.

Receive notifications about Indoco Remedies Limited in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.